New Drug: Umbralisib for relapsed/refractory follicular and marginal zone lymphoma
|New Drug: Umbralisib for relapsed/refractory follicular and marginal zone lymphoma|
Blood (2020) 136 (Supplement 1): 34–35
Zinzani PL, et al. Umbralisib, the Once Daily Dual Inhibitor of PI3Kδ and Casein Kinase-1ε Demonstrates Clinical Activity in Patients with Relapsed or Refractory Indolent Non-Hodgkin Lymphoma: Results from the Phase 2 Global Unity-NHL Trialhttps://doi.org/10.1182/blood-2020-134851
Altai Chemo Planner
Quickly Prepare Accurate Chemotherapy Orders
Altai Chemo Planner employs Altai Protocol Library that includes over 1000 chemotherapy protocols for both Hematology and Oncology. You can find major guidelines' protocols, parenteral, and oral, in the library. Altai Protocol Library is frequently and regularly updated.